Literature DB >> 18375482

Trends in circulating concentrations of total homocysteine among US adolescents and adults: findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Surveys.

Christine M Pfeiffer1, John D Osterloh, Jocelyn Kennedy-Stephenson, Mary Frances Picciano, Elizabeth A Yetley, Jeanne I Rader, Clifford L Johnson.   

Abstract

BACKGROUND: The National Health and Nutrition Examination Survey (NHANES) has monitored total homocysteine (tHcy) concentrations in a nationally-representative sample of the US population since 1991. Until recently, however, data could not be compared across survey periods because of changes in analytical methods and specimen matrices. Such an analysis of these data could supplement current knowledge regarding whether the US folic acid fortification program has modified national plasma tHcy concentrations.
METHODS: We examined tHcy data in the prefortification NHANES III survey (phase II, 1991-1994) and in 3 postfortification survey periods (1999-2000, 2001-2002, and 2003-2004). We applied method adjustment equations to the survey data based on method comparison studies of separate samples. Persons with chronic kidney disease were excluded from the analyses.
RESULTS: Mean plasma tHcy concentrations decreased by 8%, 9%, and 10% for adolescent, adult, and older men and by 6%, 3%, and 13% for women, respectively, from before to after fortification. Concentrations remained unchanged between the first and third postfortification survey periods. Prevalence estimates of increased plasma tHcy concentrations (>13 micromol/L) for older men and women decreased from prefortification (32% and 20%, respectively) to postfortification (14% and 5%, respectively) but remained unchanged thereafter (16% and 14%, respectively [males] and 5% and 9%, respectively [females]).
CONCLUSIONS: After adjusting for method changes, we quantified a prefortification to postfortification decrease in circulating tHcy concentrations of about 10% in a national sample of the US population. This change is similar to effects seen in intervention trials with folic acid and in smaller observational studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375482     DOI: 10.1373/clinchem.2007.100214

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  20 in total

1.  Serum homocysteine and folate concentrations among a US cohort of adolescents before and after folic acid fortification.

Authors:  Daniel A Enquobahrie; Henry A Feldman; Deanna H Hoelscher; Lyn M Steffen; Larry S Webber; Michelle M Zive; Eric B Rimm; Meir J Stampfer; Stavroula K Osganian
Journal:  Public Health Nutr       Date:  2012-10       Impact factor: 4.022

2.  Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12.

Authors:  Regan L Bailey; Ralph Carmel; Ralph Green; Christine M Pfeiffer; Mary E Cogswell; John D Osterloh; Christopher T Sempos; Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2011-06-15       Impact factor: 7.045

3.  Modeling a methylmalonic acid-derived change point for serum vitamin B-12 for adults in NHANES.

Authors:  Regan L Bailey; Ramon A Durazo-Arvizu; Ralph Carmel; Ralph Green; Christine M Pfeiffer; Christopher T Sempos; Alicia Carriquiry; Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2013-06-26       Impact factor: 7.045

4.  A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial.

Authors:  Michele L Mietus-Snyder; Mark K Shigenaga; Jung H Suh; Swapna V Shenvi; Ashutosh Lal; Tara McHugh; Don Olson; Joshua Lilienstein; Ronald M Krauss; Ginny Gildengoren; Joyce C McCann; Bruce N Ames
Journal:  FASEB J       Date:  2012-05-01       Impact factor: 5.191

5.  Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline.

Authors:  Christine C Tangney; Yuxiao Tang; Denis A Evans; Martha Clare Morris
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

6.  Clinical utility of genotyping the 677C>T variant of methylenetetrahydrofolate reductase in humans is decreased in the post-folic acid fortification era.

Authors:  Michael Y Tsai; Catherine M Loria; Jing Cao; Yongin Kim; David Siscovick; Pamela J Schreiner; Naomi Q Hanson
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

7.  Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.

Authors:  A David Smith; Stephen M Smith; Celeste A de Jager; Philippa Whitbread; Carole Johnston; Grzegorz Agacinski; Abderrahim Oulhaj; Kevin M Bradley; Robin Jacoby; Helga Refsum
Journal:  PLoS One       Date:  2010-09-08       Impact factor: 3.240

8.  B-vitamin status and bone mineral density and risk of lumbar osteoporosis in older females in the United States.

Authors:  Regan L Bailey; Anne C Looker; Zhaohui Lu; Ruzong Fan; Heather A Eicher-Miller; Tala H Fakhouri; Jaime J Gahche; Connie M Weaver; James L Mills
Journal:  Am J Clin Nutr       Date:  2015-07-29       Impact factor: 7.045

9.  Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.

Authors:  Gwenaëlle Douaud; Helga Refsum; Celeste A de Jager; Robin Jacoby; Thomas E Nichols; Stephen M Smith; A David Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

10.  Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.

Authors:  Yiqing Song; Nancy R Cook; Christine M Albert; Martin Van Denburgh; JoAnn E Manson
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.